Perceptive Advisors - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$31,092,899
+33.9%
1,517,467
+29.9%
1.04%
+54.3%
Q2 2023$23,215,373
+56.2%
1,168,363
+34.6%
0.67%
+53.1%
Q1 2023$14,864,249
-29.6%
867,732
-19.5%
0.44%
-26.0%
Q4 2022$21,100,452
+164.4%
1,078,204
+115.6%
0.59%
+155.6%
Q3 2022$7,980,000
-50.3%
500,000
-57.2%
0.23%
-53.9%
Q2 2022$16,056,000
-39.7%
1,166,883
-30.5%
0.50%
-5.6%
Q1 2022$26,615,000
-68.9%
1,678,090
-57.2%
0.53%
-19.2%
Q4 2021$85,536,000
+23.9%
3,918,250
+69.6%
0.66%
-34.2%
Q3 2021$69,054,000
-71.7%
2,310,261
-58.0%
1.00%
-36.6%
Q2 2021$243,736,000
+91.6%
5,503,206
+91.9%
1.58%
-1.6%
Q1 2021$127,243,000
-31.7%
2,867,771
-15.6%
1.61%
-19.5%
Q4 2020$186,284,000
+272.3%
3,396,867
+55.2%
2.00%
+173.5%
Q3 2020$50,041,000
+9.2%
2,189,0100.0%0.73%
-1.5%
Q2 2020$45,816,000
+50.0%
2,189,0100.0%0.74%
-6.7%
Q1 2020$30,537,000
-40.1%
2,189,010
-2.2%
0.80%
-21.4%
Q4 2019$50,965,000
+121.2%
2,239,241
+13.2%
1.01%
+63.0%
Q3 2019$23,037,000
-22.3%
1,977,4120.0%0.62%
-8.8%
Q2 2019$29,661,000
+269.1%
1,977,412
+331.6%
0.68%
+200.0%
Q1 2019$8,036,000
+129.9%
458,173
+90.8%
0.23%
+70.7%
Q4 2018$3,495,000240,1730.13%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,531,800$112,336,00031.61%
RTW INVESTMENTS, LP 15,715,286$697,287,00010.88%
GREAT POINT PARTNERS LLC 760,000$33,721,0006.97%
Copernicus Capital Management, LLC 8,000$355,0005.74%
Ghost Tree Capital, LLC 325,000$14,420,0003.39%
Boxer Capital, LLC 1,466,051$65,049,0002.21%
Perceptive Advisors 2,867,771$127,243,0001.61%
SECTORAL ASSET MANAGEMENT INC 447,885$19,873,0001.51%
RA Capital Management 2,107,149$93,494,0001.41%
Cormorant Asset Management, LP 1,368,550$60,723,0001.35%
View complete list of ROCKET PHARMACEUTICALS INC shareholders